Zhao, Yan
Li, Jing-Yi
Yang, Bin
Ding, Yang-Feng
Wu, Li-Ming
Zhang, Li-Tao
Wang, Jin-Yan
Lu, Qian-Jin
Zhang, Chun-Lei
Zhang, Fu-Ren
Zhu, Xiao-Hong
Li, Yu-Mei
Tao, Xiao-Hua
Diao, Qing-Chun
Li, Lin-Feng
Lu, Jian-Yun
Man, Xiao-Yong
Li, Fu-Qiu
Xia, Xiu-Juan
Song, Jiao-Ran
Jia, Ying-Min
Zhang, Li-Bo
Chen, Bo
Zhang, Jian-Zhong
Clinical trials referenced in this document:
Documents that mention this clinical trial
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial
https://doi.org/10.1007/s40259-024-00668-z
Article History
Accepted: 16 June 2024
First Online: 31 July 2024
Declarations
:
: This study was funded by Keymed Biosciences (Chengdu) Co., Ltd.
: Jiao-Ran Song, Ying-Min Jia, Li-Bo Zhang, and Bo Chen are employees of Keymed Biosciences (Chengdu) Co., Ltd. Yan Zhao, Jing-Yi Li, Bin Yang, Yang-Feng Ding, Li-Ming Wu, Li-Tao Zhang, Jin-Yan Wang, Qian-Jin Lu, Chun-Lei Zhang, Fu-Ren Zhang, Xiao-Hong Zhu, Yu-Mei Li, Xiao-Hua Tao, Qing-Chun Diao, Lin-Feng Li, Jian-Yun Lu, Xiao-Yong Man, Fu-Qiu Li, Xiu-Juan Xia, and Jian-Zhong Zhang have no conflicts of interest that are directly relevant to the content of this article.
: This trial was conducted in accordance with the Declaration of Helsinki, Good Clinical Practice guidelines, and relevant regulations. The protocol was approved by the Institutional Review Board and independent Ethics Committee of the Peking University People’s Hospital (No. 2021PHA021-007) and the participating study centers.
: All patients provided written informed consent.
: Not applicable.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: Not applicable.
: Concept and design: JZ, YZ, BC, YJ. Drafting of the manuscript: YZ, YJ, JS. Statistical analysis: LZ. All authors contributed to the acquisition, analysis, and interpretation of data, provided critical feedback on the manuscript, approved the final manuscript for submission, and are accountable for the accuracy and integrity of the manuscript.